TrialJapanese journal of clinical oncology2023

Venetoclax plus low-dose cytarabine in patients with newly diagnosed acute myeloid leukemia ineligible for intensive chemotherapy: an expanded access study in Japan.

Noboru Asada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.